-
Antibiotic Research UK calls for clear guidance to ensure people on antibiotics do not miss out on the COVID-19 vaccine
York, UK, 9th February 2021 / Sciad Newswire / Antibiotic Research UK (ANTRUK), the UK’s only charity focused on tackling bacterial antibiotic resistance, is urging the UK Government to publish clear national guidelines about whether people on antibiotics should have the COVID-19 vaccination. The charity’s vital work providing support to people who have antibiotic-resistant infections has made it clear that…
-
G&L Scientific expandiert nach Deutschland
London, UK, 9. Februar 2021 / Sciad Newswire / Die Experten für regulatorische Angelegenheiten, G&L Scientific, freuen sich, bekannt zu geben, dass sie nun auch Kunden in Deutschland direkt unterstützen. G&L Scientific verfügt über umfangreiche praktische Erfahrung im Bereich regulatorische Angelegenheiten und bietet die Skalierbarkeit und Reichweite eines großen multinationalen Unternehmens und gleichzeitig über die Reaktionsfähigkeit, Agilität…
-
La G&L Scientific approda in Italia
London, UK, 9 febbraio 2021 / Sciad Newswire / Esperta in Affari Regolatori, la G&L Scientific è lieta di comunicare che da oggi sarà di supporto per i suoi clienti italiani. Con un’ampia esperienza lavorativa nel campo degli affari regolatori grazie ai nostri nodi globali, la G&L possiede la modularità e la copertura a livello mondiale tipica…
-
G&L Scientific étend sa présence en France
London, UK, 9 février 2021 / Sciad Newswire / Les experts en affaires réglementaires, G&L Scientific, sont heureux d’annoncer qu’ils soutiennent désormais directement leurs clients en France. Forte d’une vaste expérience pratique des affaires réglementaires dans ses centres mondiaux, la société G&L possède l’évolutivité et la couverture mondiale d’une grande multinationale, tout en offrant la réactivité, l’agilité et…
-
G&L Scientific inicia su expansión en España
Barcelona, Spain, 3rd February 2021 / Sciad Newswire / G&L Scientific, consultora multinacional líder en Asuntos Regulatorios, ha anunciado hoy su expansión en España con la apertura de nuevas oficinas en Madrid y Barcelona. Gracias a su amplia experiencia práctica en asuntos regulatorios llevada a cabo en sus centros mundiales, G&L presenta la escalabilidad y la cobertura…
-
The effect of Covid on cancer diagnosis in 2020
By Professor Gordon Wishart, Chief Medical Officer at Check4Cancer & Visiting Professor of Cancer Surgery at Anglia Ruskin School of Medicine 1000 less cancer patients diagnosed every week from April to November 2020 compared to 2019 NHS England data confirms 32,249 less cancer patients diagnosed in January-November 2020 compared to 2019 due to covid restrictions….
-
Solentim wins New Product Award at SLAS 2021
Bournemouth, UK, 29th January 2021 / Sciad Newswire / Solentim is delighted to have won a New Product Award from the Society for Laboratory Automation and Screening (SLAS), annouced this week at SLAS Digital 2021. Solentim achieved this award with the launch of its new ICON™ and STUDIUS™ technologies. ICON is the world’s first benchtop system for characterizing high productivity clones…
-
Certa Sine pump makes transporting high-viscosity 3D printing materials easy
Innovative German dental materials manufacturer relies on Certa pump technology to transport high-viscosity 3D printing materials Sinusoidal pump successfully protects and transfers media whilst simplifying maintenance and cleaning processes Falmouth, UK, 27th January 2021 / Sciad Newswire / Light-curing liquid materials are used in many 3D printing processes in the medical technology industry, especially in dentistry. However,…
-
Solentim sets new standards in productivity with the launch of ICON™ and STUDIUS™; accelerating assurance rich workflows in the development of new biologics
Bournemouth, UK, 25th January 2021 / Sciad Newswire / Solentim, the trusted global leader in cell therapy workflows enabling the creation, isolation and characterization of high value cells, is delighted to launch two new solutions to enhance the development of therapeutic antibodies. ICON™ is a benchtop system for the rapid stratification of high productivity clones and STUDIUS™ is…
-
Domainex expands executive team to support ongoing growth
Saffron Walden, UK, 21st January 2021 / Sciad Newswire / Domainex Ltd., a leading provider of integrated drug discovery services, is pleased to welcome David Cronk, CBiol, MRSB, to the team as its new Chief of Staff. The Company has also promoted long standing team member and previous Head of Chemistry, Dr Ray Boffey, to Executive Director of…